Molecular pathways in bladder cancer: Part 1

被引:28
作者
Bryan, RT [1 ]
Hussain, SA
James, ND
Jankowski, JA
Wallace, DMA
机构
[1] Queen Elizabeth Hosp, Dept Urol, Birmingham B15 2TH, W Midlands, England
[2] Queen Elizabeth Hosp, Epithelial Lab, Birmingham B15 2TH, W Midlands, England
[3] Queen Elizabeth Hosp, Div Med Sci, Birmingham B15 2TH, W Midlands, England
[4] Univ Birmingham, Inst Canc Studies, Canc Res UK, Birmingham, W Midlands, England
[5] Univ Leicester, Dept Med, Leicester, Leics, England
[6] Univ Leicester, Dept Oncol, Leicester, Leics, England
关键词
D O I
10.1111/j.1464-410X.2005.05325.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
This month, three of the mini-reviews are descriptive of bladder cancer. The first two of these relate to various aspects of molecular pathways in bladder cancer. In this ever-changing field, it is important to keep abreast of new information, and the authors from Birmingham do this for us in a way that is easy to understand and complete. The third of these reviews assesses reports of non-urothelial bladder tumours, a relatively uncommon subject. In this helpful article, the authors from Rennes classify and explain these tumours, which comprise approximate to5% of bladder tumours. Finally, authors from Cleveland classify the methods used for the diagnosis of seminal oxidative stress, sperm DNA damage and apoptosis, and the association of these with male fertility.
引用
收藏
页码:485 / 490
页数:6
相关论文
共 82 条
[1]   EPIDERMAL GROWTH-FACTOR RECEPTORS [J].
ADAMSON, ED ;
REES, AR .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 1981, 34 (03) :129-152
[2]   Apoptosis control by death and decoy receptors [J].
Ashkenazi, A ;
Dixit, VM .
CURRENT OPINION IN CELL BIOLOGY, 1999, 11 (02) :255-260
[3]   IDENTIFICATION OF THE HEPATOCYTE GROWTH-FACTOR RECEPTOR AS THE C-MET PROTOONCOGENE PRODUCT [J].
BOTTARO, DP ;
RUBIN, JS ;
FALETTO, DL ;
CHAN, AML ;
KMIECIK, TE ;
VANDEWOUDE, GF ;
AARONSON, SA .
SCIENCE, 1991, 251 (4995) :802-804
[4]   Telomerase and the maintenance of chromosome ends [J].
Bryan, TM ;
Cech, TR .
CURRENT OPINION IN CELL BIOLOGY, 1999, 11 (03) :318-324
[5]  
Bugajska U, 2002, J NATL CANCER I, V94, P1381
[6]   The IGF axis and programmed cell death [J].
Butt, AJ ;
Firth, SM ;
Baxter, RC .
IMMUNOLOGY AND CELL BIOLOGY, 1999, 77 (03) :256-262
[7]  
*CAND RES UK, 2002, CANCERSTATS
[8]   INCREASED IMMUNODETECTION OF ACIDIC FIBROBLAST GROWTH-FACTOR IN BLADDER-CANCER, DETECTABLE IN URINE [J].
CHOPIN, DK ;
CARUELLE, JP ;
COLOMBEL, M ;
PALCY, S ;
RAVERY, V ;
CARUELLE, D ;
ABBOU, CC ;
BARRITAULT, D .
JOURNAL OF UROLOGY, 1993, 150 (04) :1126-1130
[9]  
Cooke PW, 1999, J PATHOL, V188, P38
[10]   Bcl-2 expression identifies patients with advanced bladder cancer treated by radiotherapy who benefit from neoadjuvant chemotherapy [J].
Cooke, PW ;
James, ND ;
Ganesan, R ;
Burton, A ;
Young, LS ;
Wallace, DMA .
BJU INTERNATIONAL, 2000, 85 (07) :829-835